{"id":114616,"date":"2020-10-17T19:22:33","date_gmt":"2020-10-18T02:22:33","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2020\/10\/varian-gets-fda-ide-approval-to-begin-clinical-trial-of-flash-therapy"},"modified":"2020-10-17T19:22:33","modified_gmt":"2020-10-18T02:22:33","slug":"varian-gets-fda-ide-approval-to-begin-clinical-trial-of-flash-therapy","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2020\/10\/varian-gets-fda-ide-approval-to-begin-clinical-trial-of-flash-therapy","title":{"rendered":"Varian gets FDA IDE approval to begin clinical trial of FLASH therapy"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/varian-gets-fda-ide-approval-to-begin-clinical-trial-of-flash-therapy.jpg\"><\/a><\/p>\n<p>Varian has secured an investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to begin a clinical trial of FLASH therapy is an experimental treatment modality designed to deliver radiation therapy at ultra-high dose rates.<\/p>\n<p>With ultra-high dose rates, FLASH therapy is said to be delivered in less than one second and more than 100 times faster compared to conventional radiation therapy.<\/p>\n<p>The study, which is named as FAST-01(feasibility study of FLASH radiotherapy for the treatment of symptomatic bone metastases), will include the investigational use of Varian\u2019s ProBeam particle accelerator that is modified to deliver an advanced non-invasive treatment option for cancer patients.<\/p>\n<hr>\n<p>Varian has secured an IDE approval from the US Food and Drug Administration (FDA) to begin a clinical trial of FLASH therapy.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Varian has secured an investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to begin a clinical trial of FLASH therapy is an experimental treatment modality designed to deliver radiation therapy at ultra-high dose rates. With ultra-high dose rates, FLASH therapy is said to be delivered in less than one second [\u2026]<\/p>\n","protected":false},"author":534,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-114616","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/114616","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/534"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=114616"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/114616\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=114616"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=114616"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=114616"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}